Dihydroartemisinin treatment enhances radiation sensitivity and displays an inverse correlation by reducing PD-L1 levels and elevating TRIM21 expression, suggesting a potential pathway for overcoming radiation resistance in lung cancer cells by targeting the PD-L1/TRIM21 axis [67]. The gene discussed is CD274; the disease is lung cancer.